NA Selank Amidate

NA Selank Amidate

NA Selank Amidate

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal acetylation and C-terminal amidation based on the original structure of Selank.

 

SKU: 198884 Udidi:
Yabelana ngothando lwakho

NA Selank Amidate exhibits improved molecular stability and in vivo pharmacokinetic profile through a double-modification strategy of N-terminal iacetylation and C-terminal amidation based on the original structure of Selank.

This results in an increased half-life, enhanced umqobo wegazi-ubuchopho penetration efficiency, and prolonged bioactivity in both molecular and animal models.

Ngaphezu koko, NA Selank Amidate exhibits potent immunomodulation and anti-stress activity.

Ulandelelwano

ac-thr-lys-pro-arg-pro-gly-pro-nh2

Inombolo yeCAS

/

Ifomula yeemolekyuli

C35H60N12O9

Ubunzima beMolekyuli

792.94

Research Of NA Selank Amidate

1.Retained and Enhanced Efficacy

Efficacy-wise,NA Selank Amidate retains all of the characteristics of Selank, ukulawula gamma-aminobutyric acid (GABA) neurotransmission in the brain while also modulating the i-dopaminergic kwaye serotonergic systems to deliver outstanding anxiolytic kwaye antidepressant effects.

It also shows better efficacy than Selank in enhancing cognitive and neuroprotective functions, producing pronounced positive effects on learning, memory, and attention.

2.Anxiolytic and Mood-Stabilizing Effects

In a concentration-dependent and subtype-selective manner, NA Selank Amidate allosterically modulates i GABA-A receptor by potentiating the binding efficacy of GABA to its receptor or enhancing chloride ion channel opening efficiency.

This significantly increases the inhibitory tone in key brain circuits, producing marked anxiolytic effects.

Ngaphaya koko, the side effects of this anxiolytic action are significantly milder than those of conventional anxiolytic drugs, making NA Selank Amidate a more attractive mood-stabilizing compound.

3.Cognitive Enhancement and Neuroprotection

NA Selank Amidate directly activates BDNF gene transcription by inducing phosphorylation of the promoter-located CREB transcription factor and acetylation of histone H3, increasing BDNF mRNA levels 3.2-fold in hippocampal dentate gyrus granule cells and prefrontal cortical pyramidal neurons and protein secretion 2.8-fold within 24 iiyure.

This activates the TrkB receptor signaling pathway downstream, inducing the Ras-MAPK and PI3K-Act cascade to increase dendritic spine density by 39%, upregulate synaptophysin expression by 45%, and restore LTP amplitude to baseline.

This successfully prevents stress-induced hippocampal neuronal injury and cognitive decline, demonstrating distinct neuroprotective properties.

4.Immunomodulatory and Anti-Stress Effects

NA Selank Amidate is a competitive inhibitor of enkephalin-degrading enzyme, protecting endogenous opioid peptides ukusuka hydrolysis and thereby elevating their levels, while it inhibits LPS (lipopolysaccharide)-induced expression of pro-inflammatory iicytokines kuquka I-IL-6 kwaye TNF-α by 40–60% in iiastrocyte.

NA Selank Amidate also represses NF-κB nuclear translocation by interfering with the recruitment of MyD88 adaptor protein, providing protective regulation in the neuroinflammatory microenvironment.

I-COA

HPLC

NKSK

(1) Sifuna, C. R.; Mhlophe, C. M. Iiarhente zokuthomalalisa-Hypnotic ezichaphazela i-Gamma-Aminobutyric Acid Receptors: Gxininisa kwiFlunitrazepam, IGamma-Hydroxybutyric Acid, Phenibut, kunye noSelank. J Clin Pharmacol 2021, 61 Suppl 2, S114-S128. DOI: 10.1002/jcph.1922 From NLM M

(2) Into ehluphekile, A.; Kolomin, T.; Andreeva, L.; Bondarenko, E.; Myasoedov, N.; Slominsky, P.; Shadrina, M. I-Peptide Selank Yongeza isiphumo se-Diazepam ekunciphiseni ukuxhalaba kwiimeko ezingalindelekanga zoxinzelelo olungenaziphene kwiimpuku.. Behav Neurol 2017, 2017, 50910

(3) Iphini, L. G.; Nadorova, A. V.; Antipova, T. A.; Kruglov, S. V.; Kudrin, V. S.; Durnev, A. D. Selank, I-Peptide Analogue yaseTuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex

(4) Iphini, L. G.; Nadorova, A. V.; Seredenin, S. B. I-Selank inhibits i-Ethanol-Induced Hyperlocomotion kunye ne-Manifestation of Behavioral Sensitization kwi-DBA/2 Mice. Inkunzi Exp Biol Med 2016, 162 (1), 56-59. DOI: 10.1007/s10517-016-3544-6 From NLM Medline.

(5) Iindleko, N. V.; Sokolov, O.; Gabaeva, M. V.; Grivennikov, I. A.; Andreeva, L. A.; Miasoedov, N. F.; Zozulia, A. A. [I-Semax kunye ne-selank inqanda i-enkephalin-degrading enzymes kwi-serum yabantu]]. Bioorg Khim 2001, 27 (3), 180-183. DOI: 10.1023/a:10113730028

(6) Andaz, G. G.; Teleshova, E. S.; Bochkarev, V. K.; Koschelev, V. V.; Syunyakov, T. S. P.3.036 Inoveli anxiolytic Selank: Iziphumo zeSigaba II solingo lwezonyango. I-European Neuropsychopharmacology 2005, 15, S159-S160. DOI: 10.1016/s0924-977x(05)80332-3.

(7) Slominsky, P. A.; Shadrina, M. I.; Kolomin, T. A.; Stavrovskaya, A. V.; Filatova, E. V.; Andreeva, L. A.; Illarioshkin, S. N.; Myasoedov, N. F. I-Peptides semax kunye ne-selank ichaphazela indlela yokuziphatha kweempuku nge-6-OHDA eyenzelwe i-PD-efana ne-parkinsonism. Dokl Biol Sc

(8) Sollertinskaja, T. N.; Shorokhov, M. V.; Myasoedov, N. F. Iziphumo ze-cerebroprotective ze-Semax kunye ne-Selank kwiiprimates kwiintlobo ezahlukeneyo ze-neurosis. Ijenali yeHlabathi yePsychophysiology 2008, 69 (3). DOI: 10.1016/j.ijpsycho.2008.05.356.

Ulandelelwano:

ac-thr-lys-pro-arg-pro-gly-pro-nh2

CAS:

/

M.W:

792.94 g/mol

Ekhaya Khangela Whatsapp Iinkonzo Imveliso